COMP <GO>
GKOS vs UNH // FREE CASH FLOW YIELD
Glaukos Corporation (NYSE) VS. UnitedHealth Group Incorporated (NYSE) • 15-METRIC TALLY: GKOS 4
— UNH 10
▲ FREE CASH FLOW YIELD LEADER: UNH
LAST: $237.60 (-2.01%) • MKT CAP: $14.35B
fcf-yield
-0.16%
LAST: $406.97 (-0.96%) • MKT CAP: $364.66B
fcf-yield
6.48%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (GKOS VS. UNH)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | GKOS | UNH | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 55.70% | 88.57% | -32.87 | UNH | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -13.70% | 11.47% | -25.17 | UNH | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | 16.4x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield ACTIVE | -0.16% | 6.48% | -6.64 | UNH | /fcf-yield <GO> |
| Operating Margin | -39.30% | 4.82% | -44.12 | UNH | /operating-margins <GO> |
| Net Profit Margin | -37.00% | 3.14% | -40.14 | UNH | /net-margins <GO> |
| Revenue Growth (YoY) | 32.30% | 6.46% | +25.84 | GKOS | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 2.28% | -2.28 | UNH | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 26.00 | 3.12 | +22.88 | GKOS | /balance-sheet <GO> |
| Piotroski F-Score Quality | 5/9 | 7/9 | -2.00 | UNH | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 7.00% | 6.74% | +0.26 | UNH | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 82.6 | 56.0 | +26.53 | GKOS | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.04 | 0.33 | +0.71 | GKOS | /macro-sensitivity <GO> |
| Forward P/E Multiple | 34.0x | 17.1x | +16.91 | UNH | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $14.35B | $364.66B | -$350.31B | UNH | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | GKOS REV | UNH REV | GKOS GROSS % | UNH GROSS % | GKOS FCF | UNH FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $507.4M | $447.57B | 55.7% | 88.7% | -$22.5M | $16.07B |
| FY 2024 | $383.5M | $400.28B | 75.5% | 88.3% | -$67.6M | $20.70B |
| FY 2023 | $314.7M | $371.62B | 44.0% | 89.6% | -$71.9M | $25.68B |
| FY 2022 | — | $324.16B | — | 89.6% | — | $23.40B |
| FY 2021 | — | $287.60B | — | 89.2% | — | $19.89B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
GKOS // BETA 1.04
UNH // BETA 0.33